Veradigm Current Ratio 2010-2022 | MDRX
Veradigm Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2022-12-31 | $0.68B | $0.23B | 2.95 |
2022-09-30 | $0.81B | $0.25B | 3.20 |
2022-06-30 | $0.83B | $0.26B | 3.23 |
2022-03-31 | $1.54B | $0.65B | 2.38 |
2021-12-31 | $0.65B | $0.49B | 1.33 |
2021-09-30 | $0.81B | $0.57B | 1.42 |
2021-06-30 | $0.84B | $0.60B | 1.41 |
2021-03-31 | $1.14B | $0.88B | 1.29 |
2020-12-31 | $1.15B | $0.94B | 1.23 |
2020-09-30 | $0.95B | $0.75B | 1.27 |
2020-06-30 | $0.87B | $1.11B | 0.78 |
2020-03-31 | $0.91B | $1.16B | 0.78 |
2019-12-31 | $0.84B | $1.21B | 0.70 |
2019-09-30 | $0.77B | $1.18B | 0.66 |
2019-06-30 | $0.80B | $0.88B | 0.91 |
2019-03-31 | $0.83B | $0.80B | 1.04 |
2018-12-31 | $0.86B | $0.80B | 1.08 |
2018-09-30 | $0.84B | $0.89B | 0.94 |
2018-06-30 | $0.86B | $0.91B | 0.94 |
2018-03-31 | $0.91B | $0.89B | 1.02 |
2017-12-31 | $0.86B | $0.89B | 0.96 |
2017-09-30 | $0.67B | $0.68B | 0.98 |
2017-06-30 | $0.62B | $0.67B | 0.93 |
2017-03-31 | $0.63B | $0.70B | 0.90 |
2016-12-31 | $0.60B | $0.67B | 0.91 |
2016-09-30 | $0.59B | $0.63B | 0.94 |
2016-06-30 | $0.59B | $0.61B | 0.98 |
2016-03-31 | $0.54B | $0.54B | 0.99 |
2015-12-31 | $0.54B | $0.51B | 1.05 |
2015-09-30 | $0.55B | $0.49B | 1.12 |
2015-06-30 | $0.54B | $0.52B | 1.04 |
2015-03-31 | $0.56B | $0.54B | 1.04 |
2014-12-31 | $0.49B | $0.52B | 0.93 |
2014-09-30 | $0.55B | $0.52B | 1.05 |
2014-06-30 | $0.54B | $0.52B | 1.05 |
2014-03-31 | $0.54B | $0.53B | 1.02 |
2013-12-31 | $0.54B | $0.52B | 1.04 |
2013-09-30 | $0.56B | $0.52B | 1.07 |
2013-06-30 | $0.59B | $0.54B | 1.10 |
2013-03-31 | $0.62B | $0.63B | 0.99 |
2012-12-31 | $0.57B | $0.52B | 1.11 |
2012-09-30 | $0.63B | $0.54B | 1.17 |
2012-06-30 | $0.66B | $0.56B | 1.16 |
2012-03-31 | $0.72B | $0.56B | 1.30 |
2011-12-31 | $0.66B | $0.50B | 1.32 |
2011-09-30 | $0.59B | $0.46B | 1.28 |
2011-06-30 | $0.61B | $0.49B | 1.25 |
2011-03-31 | $0.60B | $0.45B | 1.32 |
2010-12-31 | $0.58B | $0.43B | 1.34 |
2010-09-30 | $0.55B | $0.39B | 1.43 |
2010-06-30 | $0.00B | 0.00 | |
2010-05-31 | $0.41B | $0.21B | 1.92 |
2010-03-31 | $0.00B | 0.00 | |
2010-02-28 | $0.35B | $0.19B | 1.82 |
2009-12-31 | $0.29B | $0.16B | 1.87 |
2009-11-30 | $0.29B | $0.16B | 1.84 |
2009-09-30 | $0.00B | 0.00 | |
2009-08-31 | $0.28B | $0.16B | 1.74 |
2009-05-31 | $0.26B | $0.16B | 1.59 |
2009-02-28 | $0.29B | $0.17B | 1.66 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.476B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.476B | 53.14 |
Tempus AI (TEM) | United States | $9.826B | 0.00 |
Hims & Hers Health (HIMS) | United States | $9.069B | 145.79 |
Inspire Medical Systems (INSP) | United States | $4.756B | 92.38 |
IRhythm Technologies (IRTC) | United States | $4.186B | 0.00 |
Privia Health (PRVA) | United States | $2.829B | 212.00 |
Enovis (ENOV) | United States | $2.016B | 12.47 |
Schrodinger (SDGR) | United States | $1.847B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.706B | 0.00 |
Phreesia (PHR) | United States | $1.512B | 0.00 |
Omnicell (OMCL) | United States | $1.460B | 31.48 |
Azenta (AZTA) | United States | $1.232B | 57.36 |
10x Genomics (TXG) | United States | $1.031B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
Talkspace (TALK) | United States | $0.537B | 319.00 |
Standard BioTools (LAB) | United States | $0.456B | 0.00 |
TruBridge (TBRG) | United States | $0.392B | 0.00 |
Claritev (CTEV) | United States | $0.362B | 0.00 |
Health Catalyst (HCAT) | United States | $0.294B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.208B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
Pulmonx (LUNG) | United States | $0.152B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
CareCloud (CCLD) | United States | $0.080B | 3.43 |
111 (YI) | China | $0.072B | 0.00 |
P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
HeartBeam (BEAT) | United States | $0.061B | 0.00 |
Outset Medical (OM) | United States | $0.044B | 0.00 |
Zepp Health (ZEPP) | China | $0.039B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
Precipio (PRPO) | United States | $0.011B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |